Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 3,084	$ 13,966
Accounts receivable, net of allowance of $2,115 and $1,789 as of June 30, 2023 and December 31, 2022, respectively	2,812	4,452
Notes receivable	2,072	2,514
Inventory	5,738	5,308
Prepaid expenses and other current assets	4,331	7,262
Total current assets	18,037	33,502
Property and equipment, net	72,624	75,655
Goodwill	90,061	119,694
Intangible assets, net	12,107	120,994
Right-of-use assets - operating leases	13,100	13,060
Restricted cash	14,825	14,836
Inventory, net of current portion	25,339	22,949
Other long-term assets	326	376
Total assets	246,419	401,066
Current liabilities:
Accounts payable	12,448	5,810
Accrued expenses and other current liabilities	9,401	9,069
Accrued R&D software	24,000	7,333
Short-term debt ($16,816 at fair value and $16,982 unpaid principal balance at June 30, 2023)	16,816	37,603
Deferred revenue	2,311	2,273
Total current liabilities	64,976	62,088
Deferred revenue, net of current portion	2,356	2,219
Acquisition-related contingent consideration	1,606	105,945
Noncurrent lease liabilities - operating	28,102	27,985
Noncurrent accrued R&D software	7,250
Long-term debt	17,027
Warrant liabilities	6,277	3,598
Deferred income tax liabilities	9	9
Other liabilities	315	321
Total liabilities	127,918	202,165
Commitments and Contingencies (Note 9)
Stockholders’ equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding at June 30, 2023 and December 31, 2022
Common Stock, $0.0001 par value, 730,000,000 shares authorized, 180,817,245 issued and outstanding as of June 30, 2023; 730,000,000 shares authorized, 148,921,187 issued and outstanding as of December 31, 2022	18	15
Additional paid-in capital	873,557	844,373
Accumulated other comprehensive income	2,388	9
Accumulated deficit	(757,462)	(645,496)
Total stockholders’ equity	118,501	198,901
Total liabilities and stockholders' equity	$ 246,419	$ 401,066